HMG-CoA-reductase-inhibitorsImmune-mediated necrotising myopathy : 25 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2018卷 / 1期

关键词：

D O I：

10.1007/s40278-024-63684-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：225 / 225

相关论文

共 50 条

[1] AtorvastatinAnti-HMG-COA reductase antibody-associated immune-mediated necrotising myopathy: 2 case reports
Reactions Weekly, 2024, 2024 (1) : 68 - 68
[2] HMG-CoA-reductase-inhibitorsStatin-associated autoimmune myopathy: 6 case reports
Reactions Weekly, 2021, 1860 (1) : 188 - 189
[3] HMG-CoA reductase inhibitors - Myopathy in patients with genetic mutations (four case reports)
不详
MOLECULAR DIAGNOSIS & THERAPY, 2008, 12 (04) : 262 - 262
[4] Pitavastatin/prednisoloneAnti-HMG-CoA reductase non-severe immune-mediated necrotising myopathy and mild diabetes mellitus : case report
Reactions Weekly, 2024, 2020 (1) : 388 - 388
[5] AtorvastatinAnti-HMG-CoA reductase–associated myopathy: case report
Reactions Weekly, 2022, 1931 (1) : 117 - 117
[6] Atorvastatin/pravastatin/simvastatinImmune necrotising myopathy: 25 case reports
Reactions Weekly, 2010, 1294 (1) : 11 - 11
[7] PembrolizumabImmune-mediated necrotising myopathy: 2 case reports
Reactions Weekly, 2022, 1903 (1) : 318 - 318
[8] AntihyperlipidaemicsImmune-mediated necrotising myopathy: 13 case reports
Reactions Weekly, 2015, 1581 (1) : 34 - 34
[9] AtorvastatinImmune-mediated necrotising myopathy: 4 case reports
Reactions Weekly, 2018, 1688 (1) : 36 - 36
[10] HMG-COA REDUCTASE INHIBITORS, GEMFIBROZIL, AND MYOPATHY
TOBERT, JA
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (12): : 862 - 862

← 1 2 3 4 5 →